Clofazimine API (CAS No: 2030-63-9): Complete Pharmaceutical Guide for Manufacturers, Suppliers, and Global Buyers

Introduction to Clofazimine API

Clofazimine API (CAS No: 2030-63-9) is one of the most important antimycobacterial active pharmaceutical ingredients used in the global pharmaceutical industry. The API is widely recognized for its role in the treatment of leprosy and certain multidrug-resistant bacterial infections. Due to the increasing global focus on infectious disease management, pharmaceutical companies, healthcare organizations, and formulation manufacturers are actively searching for reliable Clofazimine API Manufacturer Supplier in India to ensure uninterrupted access to high-quality pharmaceutical raw materials.

Clofazimine-API-CAS-No-2030-63-9-Complete-Pharmaceutical-Guide-for-Manufacturers-Suppliers-and-Global-Buyers

Clofazimine belongs to the riminophenazine class of compounds and is known for its unique antimicrobial and anti-inflammatory properties. Unlike many conventional antibacterial agents, Clofazimine offers dual therapeutic benefits, which makes it highly valuable in multidrug treatment regimens. Pharmaceutical researchers and healthcare professionals continue exploring its applications in resistant infections because antimicrobial resistance has become a major global healthcare concern. This growing therapeutic relevance has significantly increased demand for pharmaceutical-grade Clofazimine API in both domestic and international pharmaceutical markets.

India has become a leading destination for pharmaceutical API sourcing due to its advanced manufacturing infrastructure, skilled scientific workforce, export-oriented production systems, and cost-effective supply capabilities. Global pharmaceutical buyers often prefer Indian suppliers because they provide high-quality APIs supported by regulatory documentation, scalable bulk production, and export-ready packaging. As a result, searches for Bulk Clofazimine Manufacturer Supplier in India, Pharmaceutical Clofazimine Manufacturer Supplier, and Clofazimine Supplier in Maharashtra India continue increasing rapidly across global pharmaceutical industries.

What is Clofazimine API?

Clofazimine is a lipophilic phenazine dye derivative primarily used in antimycobacterial therapies. The API is extensively utilized in the treatment of multibacillary leprosy and erythema nodosum leprosum as part of multidrug therapy regimens. International healthcare organizations recognize Clofazimine as an important pharmaceutical ingredient because of its ability to suppress bacterial growth while also reducing inflammatory reactions associated with chronic infections.

The API is identified globally by CAS Number 2030-63-9 and has the molecular formula C27H22Cl2N4. Clofazimine typically appears as a reddish-brown crystalline powder with low water solubility due to its highly lipophilic nature. This characteristic allows the compound to accumulate in fatty tissues and macrophages, providing prolonged therapeutic activity during long-term treatment regimens. Pharmaceutical companies manufacturing anti-infective formulations carefully evaluate the quality and consistency of Clofazimine API because treatment effectiveness depends heavily on purity and manufacturing precision.

Pharmaceutical buyers generally prefer suppliers capable of providing complete documentation support such as COA, MSDS, stability reports, impurity profiles, and technical specifications. Reliable suppliers offering regulatory support and export-compliant packaging are highly preferred in regulated and semi-regulated pharmaceutical markets. This growing demand has strengthened the position of trusted Indian pharmaceutical suppliers within the global API supply chain.

Therapeutic Applications of Clofazimine API

Clofazimine API plays a major role in the treatment of chronic infectious diseases caused by mycobacterial organisms. Its primary therapeutic application remains in leprosy management programs where it is administered alongside other antimicrobial agents to reduce bacterial resistance and improve treatment outcomes. The API demonstrates slow but highly effective bactericidal activity against Mycobacterium leprae, making it suitable for long-term multidrug therapy regimens.

One of the most important clinical advantages of Clofazimine is its anti-inflammatory activity. Patients suffering from erythema nodosum leprosum often experience severe inflammatory complications during treatment. Clofazimine helps control these inflammatory reactions, improving patient management and therapeutic effectiveness. This dual therapeutic functionality differentiates Clofazimine from many conventional antimicrobial compounds and significantly increases its pharmaceutical value worldwide.

Another reason for increasing global demand is the growing research involving Clofazimine in drug-resistant tuberculosis treatment programs. Healthcare systems worldwide are focusing heavily on antimicrobial resistance management, and pharmaceutical researchers continue evaluating the role of Clofazimine-containing regimens in resistant mycobacterial infections. As a result, international pharmaceutical companies are actively searching for dependable Pharmaceutical Clofazimine Manufacturer Supplier companies capable of providing commercial-scale supply supported by international quality standards.

Chemical Properties and Technical Specifications

The chemical and technical profile of Clofazimine API is extremely important for pharmaceutical formulation scientists and procurement teams. Clofazimine is generally supplied as a reddish-brown crystalline powder with high lipophilicity and low aqueous solubility. These physical properties contribute significantly to its long tissue retention time and sustained therapeutic activity.

Pharmaceutical-grade Clofazimine API must meet strict quality specifications related to assay values, impurity levels, residual solvents, particle size distribution, and microbiological safety. Manufacturers producing high-quality APIs implement advanced analytical testing methods including chromatographic analysis, impurity profiling, and stability studies to ensure batch-to-batch consistency. Maintaining consistent pharmaceutical standards becomes particularly important because variations in API quality may affect formulation stability and therapeutic performance.

International pharmaceutical buyers searching for a trusted Bulk Clofazimine Manufacturer Supplier in India generally prioritize manufacturers with strong quality assurance systems and modern analytical laboratories. Reliable suppliers also provide technical documents required for formulation development and regulatory registration. Export-oriented packaging, moisture protection systems, and controlled storage conditions are additional factors that pharmaceutical buyers carefully evaluate during supplier selection.

Mechanism of Action of Clofazimine API

Clofazimine demonstrates a unique mechanism of action that distinguishes it from many conventional antibacterial compounds. Research suggests that the API interacts directly with bacterial cell membranes, disrupting membrane integrity and interfering with essential cellular functions required for bacterial survival. This membrane-targeting activity contributes to its effectiveness against mycobacterial organisms.

The API also appears to generate reactive oxygen species within bacterial cells, which further enhances antimicrobial activity. Its lipophilic structure allows Clofazimine to accumulate inside macrophages and fatty tissues, supporting prolonged therapeutic effects during long-term treatment regimens. These pharmacological properties make Clofazimine especially valuable in chronic infectious disease management programs where sustained antimicrobial action is necessary.

Apart from its antimicrobial properties, Clofazimine also demonstrates strong anti-inflammatory effects. The API appears to influence immune pathways and suppress inflammatory reactions associated with chronic infections. This characteristic is particularly beneficial in managing erythema nodosum leprosum complications. Because of these combined therapeutic benefits, pharmaceutical companies continue investing in formulations containing high-quality Clofazimine API for global healthcare markets.

Global Pharmaceutical Market Demand for Clofazimine API

The international pharmaceutical market for antimycobacterial APIs continues expanding because healthcare systems remain focused on infectious disease treatment and antimicrobial resistance management. Clofazimine API has gained increasing commercial importance due to its role in leprosy treatment and growing interest in resistant infection therapies. Pharmaceutical procurement agencies, healthcare manufacturers, and formulation companies worldwide actively seek dependable API suppliers capable of supporting long-term commercial requirements.

One of the key drivers behind rising market demand is the continued prevalence of chronic mycobacterial infections in certain regions. Healthcare organizations require uninterrupted access to high-quality pharmaceutical ingredients to maintain treatment programs effectively. Pharmaceutical companies involved in anti-infective formulations therefore prioritize long-term partnerships with reliable API manufacturers.

India has emerged as one of the strongest suppliers within this pharmaceutical segment because Indian manufacturers combine competitive pricing with advanced manufacturing expertise. Searches for Clofazimine API Manufacturer Supplier in India continue growing because pharmaceutical buyers trust Indian companies for scalable production, export-focused logistics, technical support, and international-quality manufacturing standards.

Why India is a Preferred Hub for Clofazimine API Manufacturing

India’s pharmaceutical industry has become one of the world’s largest API manufacturing ecosystems. The country offers several advantages including advanced production infrastructure, experienced scientific professionals, affordable manufacturing costs, and efficient export logistics networks. These strengths have positioned India as a preferred sourcing destination for pharmaceutical APIs across global markets.

Indian pharmaceutical manufacturers are recognized for their ability to produce APIs in commercial quantities while maintaining internationally accepted quality standards. Many facilities operate under WHO-GMP-aligned manufacturing systems and support buyers with technical documentation such as COA, MSDS, stability reports, and regulatory data. These capabilities have significantly strengthened the reputation of Indian pharmaceutical exporters worldwide.

Another important factor contributing to India’s pharmaceutical growth is its export-focused infrastructure. Indian suppliers regularly export APIs to regulated, semi-regulated, and emerging markets across Europe, Asia, Africa, Latin America, and North America. As international pharmaceutical demand continues increasing, reliable Bulk Clofazimine Manufacturer Supplier in India companies are expected to remain highly competitive within the global pharmaceutical supply chain.

Clofazimine Supplier in Maharashtra India

Maharashtra is widely recognized as one of India’s leading pharmaceutical manufacturing states. The region hosts numerous API production facilities, pharmaceutical research centers, export-oriented businesses, and healthcare manufacturing companies. Strong industrial infrastructure and logistics connectivity make Maharashtra highly favorable for pharmaceutical exports.

Pharmaceutical buyers searching for a dependable Clofazimine Supplier in Maharashtra India usually prioritize manufacturers capable of ensuring consistent product quality, timely delivery, and export-ready packaging solutions. Maharashtra-based suppliers benefit from strong transportation access through ports, highways, and industrial corridors, enabling efficient domestic and international distribution.

The pharmaceutical ecosystem in Maharashtra also supports technological advancement and quality-driven manufacturing practices. Companies operating in this region frequently invest in modern analytical laboratories, quality control systems, and regulatory compliance infrastructure to meet growing global pharmaceutical standards.

Bulk Clofazimine Manufacturer Supplier in India

Bulk pharmaceutical procurement requires manufacturing partners capable of supporting large-volume production while maintaining strict quality consistency. Indian pharmaceutical manufacturers have developed extensive infrastructure for handling commercial-scale API manufacturing operations efficiently.

Reliable bulk suppliers typically offer customized packaging options such as HDPE drums, fiber drums, and tamper-proof export packaging to protect product stability during transportation. They also provide flexible shipment scheduling and long-term commercial agreements to support pharmaceutical formulation companies worldwide.

International pharmaceutical buyers often prefer working with experienced Bulk Clofazimine Manufacturer Supplier in India companies because these suppliers combine affordability with dependable manufacturing systems and export capabilities. Strong quality management systems and scalable production capacity make Indian suppliers highly competitive in global pharmaceutical markets.

Pharmaceutical Clofazimine Manufacturer Supplier Selection Guide

Selecting the right pharmaceutical supplier is one of the most important decisions for formulation manufacturers and procurement teams. Buyers should evaluate suppliers carefully based on quality standards, manufacturing capabilities, export experience, regulatory support, and documentation systems.

A trusted Pharmaceutical Clofazimine Manufacturer Supplier should maintain advanced analytical testing facilities and validated production processes capable of ensuring consistent pharmaceutical quality. Suppliers should also provide complete technical documentation required for formulation development and regulatory approvals.

Supplier Evaluation Criteria	Importance
Product Purity	Ensures therapeutic effectiveness
Batch Consistency	Supports formulation reliability
Regulatory Documentation	Simplifies market registration
Packaging Standards	Maintains product stability
Export Experience	Supports global delivery
Technical Support	Assists pharmaceutical development

Careful supplier evaluation helps pharmaceutical companies establish long-term sourcing partnerships capable of supporting stable production operations and international commercial growth.

Company Overview – Swapnroop Drugs and Pharmaceuticals

Swapnroop Drugs and Pharmaceuticals is a trusted pharmaceutical manufacturer, exporter, and supplier based in Maharashtra, India. Established in 2013, the company specializes in supplying high-quality pharmaceutical raw materials including APIs, excipients, pellets, granules, and specialty pharmaceutical ingredients to domestic and international markets.

The company focuses on quality-driven manufacturing systems supported by regulatory documentation assistance, export-ready packaging, and customer-centric service. Swapnroop Drugs and Pharmaceuticals supports pharmaceutical manufacturers, distributors, and healthcare companies with COA, MSDS, stability data, and technical documentation required for commercial pharmaceutical operations.

With a strong emphasis on consistency, quality assurance, and timely delivery, the company continues strengthening its global pharmaceutical presence. Their WHO-GMP-aligned manufacturing approach and commitment to customer satisfaction have made them a preferred sourcing partner for pharmaceutical buyers worldwide.

Conclusion

Clofazimine API remains one of the most valuable antimycobacterial pharmaceutical ingredients used in modern infectious disease therapy. Its unique antimicrobial and anti-inflammatory properties make it highly important in leprosy treatment programs and emerging resistant infection management strategies. Growing global healthcare focus on antimicrobial resistance continues increasing pharmaceutical demand for high-quality Clofazimine API.

India has established itself as a leading global pharmaceutical manufacturing destination because of its advanced infrastructure, export capabilities, and competitive production systems. Pharmaceutical buyers worldwide actively search for reliable Clofazimine API Manufacturer Supplier in India companies capable of providing pharmaceutical-grade quality, technical support, and scalable supply solutions.

For pharmaceutical companies, selecting a dependable supplier capable of ensuring consistent quality, regulatory compliance, and reliable delivery is critical for long-term commercial success. Trusted companies like Swapnroop Drugs and Pharmaceuticals continue supporting global pharmaceutical industries with reliable API sourcing solutions and customer-focused pharmaceutical services.

Frequently Asked Questions

What is Clofazimine API used for?

Clofazimine API is primarily used in the treatment of leprosy and certain multidrug-resistant mycobacterial infections.

What is the CAS Number of Clofazimine?

The CAS Number of Clofazimine is 2030-63-9.

Why is India preferred for Clofazimine API sourcing?

India offers advanced pharmaceutical infrastructure, cost-effective manufacturing, export capabilities, and high-quality API production systems.

What documents should buyers request from a Clofazimine supplier?

Buyers should request COA, MSDS, stability reports, impurity profiles, and technical documentation support.

What should buyers evaluate before selecting a Bulk Clofazimine Manufacturer Supplier in India?

Buyers should evaluate quality systems, manufacturing capacity, export experience, regulatory support, and packaging standards.

Why choose Swapnroop Drugs and Pharmaceuticals?

Swapnroop Drugs and Pharmaceuticals offers high-quality pharmaceutical raw materials, export-ready packaging, documentation support, scalable supply capabilities, and reliable customer service for global pharmaceutical markets.